Literature DB >> 18379737

A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease.

Maria Teresa Ferrò1, Diego Franciotta, Tommaso Riccardi, Elisabetta D'Adda, Elsa Mainardi, Alessandro Montanelli.   

Abstract

Multiple sclerosis (MS) and coeliac disease (CD) are an uncommon association. Recently "MS-like illness and CNS white-matter abnormalities" have been demonstrated in patients with CD. We report the case of a 19-year-old female with MS, who presented an episode of headache at onset of disease and developed acute hepatitis (AH) 14 months later. After the diagnosis of AH, an occult CD, confirmed by jejunal biopsy, was disclosed. Constipation was the only gastrointestinal symptom. A serum sample collected before onset of MS was positive for CD. Anti-central nervous system antibodies were negative in both retrospective and current serum samples. Conclusions The concomitant presence of MS with atypical onset, AH and CD likely represents an unusual chance association in our patient but inflammatory immune-mediated damage of the central nervous system triggered by gluten could not be excluded.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379737     DOI: 10.1007/s10072-008-0855-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

Review 1.  Gluten sensitivity as a neurological illness.

Authors:  M Hadjivassiliou; R A Grünewald; G A B Davies-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

2.  Jejunal morphology in multiple sclerosis.

Authors:  M C Bateson; D Hopwood; J B MacGillivray
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321

Review 3.  MS: a CNS and systemic autoimmune disease.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Today       Date:  1989-03

4.  Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients.

Authors:  M Kieslich; G Errázuriz; H G Posselt; W Moeller-Hartmann; F Zanella; H Boehles
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

5.  Headache and CNS white matter abnormalities associated with gluten sensitivity.

Authors:  M Hadjivassiliou; R A Grünewald; M Lawden; G A Davies-Jones; T Powell; C M Smith
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

6.  Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration.

Authors:  Karkada Mohan; Devanand Pinto; Thomas B Issekutz
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

7.  Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.

Authors:  M Hadjivassiliou; M Mäki; D S Sanders; C A Williamson; R A Grünewald; N M Woodroofe; I R Korponay-Szabó
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

8.  Multiple sclerosis and occult gluten sensitivity.

Authors:  Connie D S N A Pengiran Tengah; Robert J Lock; D Joseph Unsworth; Adrian J Wills
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

Review 9.  Coeliac disease.

Authors:  Peter H R Green; Bana Jabri
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

10.  The humoral response in the pathogenesis of gluten ataxia.

Authors:  M Hadjivassiliou; S Boscolo; G A B Davies-Jones; R A Grünewald; T Not; D S Sanders; J E Simpson; E Tongiorgi; C A Williamson; N M Woodroofe
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

  10 in total
  3 in total

1.  Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis.

Authors:  Hiroki Yamaguchi; Kenji Sakai; Yoshinori Goto; Masahito Yamada
Journal:  J Neurol       Date:  2018-05-29       Impact factor: 4.849

2.  Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.

Authors:  Nilufer Kale; Murat Icen; Jale Agaoglu; Isil Yazici; Osman Tanik
Journal:  Neurol Sci       Date:  2008-10-14       Impact factor: 3.307

Review 3.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.